Current approach and future perspective for ductal carcinoma in situ of the breast
C Kanbayashi, H Iwata - Japanese journal of clinical oncology, 2017 - academic.oup.com
Ductal carcinoma in situ (DCIS) has a good prognosis with the current treatment approach,
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …
Current approach and future perspective for ductal carcinoma in situ of the breast.
C Kanbayashi, H Iwata - Japanese Journal of Clinical Oncology, 2017 - europepmc.org
Ductal carcinoma in situ (DCIS) has a good prognosis with the current treatment approach,
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …
[HTML][HTML] Current approach and future perspective for ductal carcinoma in situ of the breast
C Kanbayashi, H Iwata - Japanese Journal of Clinical Oncology, 2017 - ncbi.nlm.nih.gov
Ductal carcinoma in situ (DCIS) has a good prognosis with the current treatment approach,
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …
Current approach and future perspective for ductal carcinoma in situ of the breast.
C Kanbayashi, H Iwata - Japanese Journal of Clinical …, 2017 - search.ebscohost.com
Ductal carcinoma in situ (DCIS) has a good prognosis with the current treatment approach,
with a 10-year breast cancer-specific survival rate of 97-98%. In ductal carcinoma in situ …
with a 10-year breast cancer-specific survival rate of 97-98%. In ductal carcinoma in situ …
[PDF][PDF] Current approach and future perspective for ductal carcinoma in situ of the breast
C Kanbayashi, H Iwata - Japanese Journal of Clinical Oncology, 2017 - academic.oup.com
Ductal carcinoma in situ (DCIS) has a good prognosis with the current treatment approach,
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …
Current approach and future perspective for ductal carcinoma in situ of the breast
C Kanbayashi, H Iwata - Japanese journal of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
Ductal carcinoma in situ (DCIS) has a good prognosis with the current treatment approach,
with a 10-year breast cancer-specific survival rate of 97-98%. In ductal carcinoma in situ …
with a 10-year breast cancer-specific survival rate of 97-98%. In ductal carcinoma in situ …
[引用][C] Current approach and future perspective for ductal carcinoma in situ of the breast
C Kanbayashi, H Iwata - Japanese Journal of Clinical Oncology, 2017 - cir.nii.ac.jp
Current approach and future perspective for ductal carcinoma in situ of the breast | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Current approach and future perspective for ductal carcinoma in situ of the breast.
C Kanbayashi, H Iwata - Japanese Journal of Clinical Oncology, 2017 - europepmc.org
Ductal carcinoma in situ (DCIS) has a good prognosis with the current treatment approach,
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …
with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ …